#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15398	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2463	753.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1708	1708	C	992	C	990	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26116	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4005	811.7	0	.	n	.	0	T695C	SNP	695	695	T	1217	1217	C	927	C,G,T,A	921,4,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26116	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4005	811.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1859	1859	A	1044	A,G	1043,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26116	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4005	811.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2493	2493	C	926	C,T,A,G	922,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26116	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4005	811.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2567	2567	A	866	A,T,C	863,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26116	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4005	811.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3119	3119	C	906	C	906	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2304	folP	855	855	100.0	folP.l15.c4.ctg.1	2045	140.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1310	1312	AGC	220;222;222	A,C,G;G;C,G	217,1,1;222;221,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3861	168.2	1	SNP	p	S91F	1	.	.	271	273	TTC	758	760	TTC	186;186;185	T;T;C	186;186;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3861	168.2	1	SNP	p	D95G	1	.	.	283	285	GGC	770	772	GGC	193;195;198	G,A;G;C	192,1;195;197	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5214	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3861	168.2	1	SNP	p	G95N	0	.	.	283	285	GGC	770	772	GGC	193;195;198	G,A;G;C	192,1;195;197	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1990	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1869	132.9	1	SNP	p	G45D	0	.	.	133	135	GGC	783	785	GGC	238;236;236	G;G,T;C	238;235,1;236	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1124	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1407	99.6	0	.	n	.	0	A197.	DEL	197	197	A	799	799	A	238	A	238	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3462	177.7	1	SNP	p	D86N	0	.	.	256	258	GAC	779	781	GAC	247;249;249	G;A;C,G	247;249;248,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3462	177.7	1	SNP	p	R87W	0	.	.	259	261	CGT	782	784	CGT	251;253;254	C,A;G,A;T	249,2;252,1;254	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3462	177.7	1	SNP	p	R87I	0	.	.	259	261	CGT	782	784	CGT	251;253;254	C,A;G,A;T	249,2;252,1;254	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3462	177.7	1	SNP	p	S87R	1	.	.	259	261	CGT	782	784	CGT	251;253;254	C,A;G,A;T	249,2;252,1;254	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3462	177.7	1	SNP	p	S88P	0	.	.	262	264	TCC	785	787	TCC	253;252;256	T,G;C;C	252,1;252;256	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4356	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3255	166.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1880	1882	GGC	237;236;235	G;G;C,T	237;236;234,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1481	1483	GCA	229;229;227	G,C;C,G;A	228,1;228,1;227	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1484	1486	ATC	227;226;226	A;T;C,G	227;226;225,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1496	1498	GTG	232;233;233	G;T;G,A	232;233;232,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1496	1498	GTG	232;233;233	G;T;G,A	232;233;232,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2000	2002	ACC	245;242;240	A,G;C;C,T	244,1;242;239,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2054	2056	GCG	247;246;247	G;C,A;G,A,C	247;245,1;245,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2054	2056	GCG	247;246;247	G;C,A;G,A,C	247;245,1;245,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2177	2179	AGC	242;243;241	A;G,T;C,T	242;241,2;240,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2186	2188	GGC	234;236;234	G;G;C,T	234;236;233,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4134	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2907	177.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2204	2206	CCG	226;226;224	C;C;G,C	225;225;223,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5750	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3502	204.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1839	1841	CCG	234;235;237	C;C;G,A	234;235;235,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2400	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2279	131.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	801	801	C	172	C	172	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	20;25;26	T;T;A	20;25;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	56;56;56	C;A;T	56;56;56	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	56;56;56	A;G;T	56;56;56	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	56;56;56	T,A;A,C;C	55,1;55,1;56	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	E312G	NONSYN	934	936	GAA	176	178	GGA	2;2;2	G;G;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	292	porB1a	984	226	90.27	porB1a.l6.c17.ctg.1	412	23.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	956	958	GGA	221;223;222	G,A;G,A;A	217,4;219,4;222	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	0	.	p	.	0	.	INDELS	629	630	AA	1159	1161	TAG	252;254;255	T,C;A;G,C	246,1;250;250,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1163	1166	CAAT	250;253;255;256	C;A;A;T	250;253;255;256	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1168	1168	T	264	T,C	263,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	1	SNP	p	G120K	0	.	.	358	360	GGT	887	889	GGT	213;215;215	G,A;G,A,T;T,G	208,4;209,4,1;210,4	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	1	SNP	p	A121D	0	.	.	361	363	GCC	890	892	GCC	213;215;215	G;C,A;C	213;211,4;215	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	1972	180.5	1	SNP	p	A121N	0	.	.	361	363	GCC	890	892	GCC	213;215;215	G;C,A;C	213;211,4;215	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9996	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5353	232.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1630	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1497	135.2	1	SNP	p	V57M	1	.	.	169	171	ATG	737	739	ATG	280;280;279	A;T;G	280;280;278	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
